Renato Sampaio Carvalho
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Farmácia
Departamento:
Departamento de Biotecnologia Farmacêutica
Formação:
-
Instituto Nacional de Câncer
| Pós-Doutorado | 2013 - 2013
-
Universidade Federal do Rio de Janeiro
Ciências Biológicas (Biofísica) | Doutorado | 2008 - 2012
-
Universidade Federal do Rio de Janeiro
Química Biológica | Mestrado | 2006 - 2008
-
Universidade Federal do Rio de Janeiro
Farmácia | Graduação | 2002 - 2005
-
Centro Federal de Educação Tecnológica de Química
| Ensino Profissional de nível técnico | 1997 - 2001
Laboratórios:
Nuvens de Palavras:
Artigos:
(100.00% artigos com DOI)
Titulo | DOI | Ano |
---|---|---|
First case report and characterization of a Brazilian family with a rare hemoglobin variant¿Hb maputo | 10.1016/j.htct.2024.02.025 | 2024 |
Copper drives prion protein phase separation and modulates aggregation | 10.1126/sciadv.adi7347 | 2023 |
Espectrometria de massas: uma ferramenta versátil para a caracterização de anticorpos monoclonais terapêuticos | 10.55905/cuadv15n12-048 | 2023 |
O potencial revolucionário da imunoterapia no tratamento do Câncer de Endométrio avançado/recorrente com deficiência de enzimas de reparo ou alta instabilidade de microssatélite | 10.34119/bjhrv6n6-490 | 2023 |
From a recombinant key antigen to an accurate, affordable serological test: lessons learnt from COVID-19 for future pandemics | 10.1016/j.bej.2022.108537 | 2022 |
Galectin-3 plays an important role in endometriosis development and is a target to endometriosis treatment | 10.1016/j.mce.2019.02.007 | 2019 |
Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane | 10.1038/s41598-019-50564-8 | 2019 |
Ligand-free method to produce the anti-angiogenic recombinant Galectin-3 carbohydrate recognition domain | 10.1016/j.pep.2017.11.006 | 2018 |
Phenolic compounds from Viscum album Tinctures Enhanced Antitumor Activity in Melanoma Murine Cancer Cells | 10.1016/j.jsps.2018.01.011 | 2018 |
Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells | 10.1016/j.bbrc.2018.05.136 | 2018 |
Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus | 10.1158/0008-5472.can-17-3864 | 2018 |
Phosphofructokinase-P Modulates P44/42 MAPK Levels in HeLa Cells | 10.1002/jcb.25774 | 2017 |
BRCA1 recruitment to damaged DNA sites is dependent on CDK9 | 10.1080/15384101.2017.1295177 | 2017 |
Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole | 10.1016/j.biocel.2015.03.004 | 2015 |
Enhancer scanning to locate regulatory regions in genomic loci | 10.1038/nprot.2015.136 | 2015 |
BRCA1 Circos: a visualisation resource for functional analysis of missense variants | 10.1136/jmedgenet-2014-102766 | 2015 |
Characterization of LGALS3 (galectin-3) as a player in DNA damage response | 10.4161/cbt.28873 | 2014 |
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1 | 10.1371/journal.pone.0097766 | 2014 |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer | 10.1038/ng.2564 | 2013 |
Ketoprofen Impairs Immunosuppression Induced by Severe Sepsis and Reveals an Important Role for Prostaglandin E2 | 10.1097/SHK.0b013e318272ff8a | 2012 |
Modulation of expression and activity of cytochrome P450s and alteration of praziquantel kinetics during murine schistosomiasis | 10.1590/s0074-02762011000200016 | 2011 |
Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon | 10.1097/fpc.0b013e328349daba | 2011 |
Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models | 10.1186/1475-2875-9-81 | 2010 |
Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in mouse liver | 10.1016/j.ejphar.2009.05.030 | 2009 |
The distribution of ABCB1 polymorphisms among Brazilians: Impact of population admixture. | 10.2217/14622416.9.3.267. | 2008 |
Eventos:
(0.00% eventos com DOI)